Amgen stalls Samsung’s Enbrel biosim until 2029 in 2nd patent win of the year

Amgen stalls Samsung’s Enbrel biosim until 2029 in 2nd patent win of the year
fkansteiner
Wed, 12/01/2021 – 08:40